BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $90

Benzinga Newsdesk www.benzinga.com Positive 71.4%

Neg 0% Neu 0% Pos 71.4%

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $65 to $90.